Active Research Studies

1. Title: Safety and Efficacy of Pentavalent (G1, G2, G3, G4, and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants
   Sponsor: Merck & Co., Inc.
   Period: 2001 – 20032.
2. Title: Open-Label, Multicenter, Multiple-Dose, Phase III Study of the Population Pharmacokinetics of IV Synercid (7.5 mg/kg q8h) in 75 Pediatric Patients (RP59500V324)
   Sponsor: Aventis
   Period: 2000 – ongoing
3. Title: A prospective, Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Safety, Local Tolerability, and Clinical Outcome of Ertapenem Sodium (MK-0826) versus Ceftriaxone Sodium in Pediatric Patients with Complicated Urinary Tract Infection, Skin and Soft Tissue Infection or Community-Acquired Pneumonia
   Sponsor: Merck & Co., Inc
   Period: 2002 – ongoing
4. Title: A prospective, Multicenter, Randomized, Open-Label Comparative Study to Evaluate the Safety, Tolerability and Efficacy of Ertapenem Sodium (MK-0826) versus Ticarcillin/Clavulanate in the Treatment of Hospital Acquired Pneumonia and Complicated Intra-Abdominal Infections in Pediatric Patients
   Sponsor: Merck & Co., Inc.
   Period: 2002 – ongoing
5. Title: A Multicenter, Randomized, Open-Label, Comparative Study to Compare the Efficacy and Safety of Levofloxacin and Standard of Care Therapy in the Treatment of Children with Community-Acquired Pneumonia in the Hospitalized or Outpatient Setting
   Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
   Period: 2003-2004